Acorda Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2003
Net Income	-252.85	-65.92	-103.95	-99.59	-272.97	33.68	-223.36	-34.62	11.06	17.67	Upgrade
Depreciation & Amortization	31.6	32.81	33.95	41.3	34.57	11.48	23.23	21.58	15.01	8.47	Upgrade
Share-Based Compensation	0.48	1.49	3	8.1	14.25	21.25	32.81	36.4	33.27	29.07	Upgrade
Other Operating Activities	206.79	10.69	25.66	-10.81	95.98	84.38	264.45	6.28	-20.86	19.44	Upgrade
Operating Cash Flow	-13.98	-20.92	-41.35	-61.01	-128.17	150.79	97.14	29.65	38.48	74.65	Upgrade
Operating Cash Flow Growth	-	-	-	-	-	55.24%	227.62%	-22.95%	-48.45%	90.02%	Upgrade
Capital Expenditures	-0.26	-0.14	-0.17	-4.39	-90.43	-33.33	-13.69	-6.19	-5.92	-5.08	Upgrade
Acquisitions	0	0	0	0	0	7.88	3.66	-266.45	0	-476.15	Upgrade
Change in Investments	0	0	73.97	63.75	89.92	-150.83	0	199.75	-78.17	190.11	Upgrade
Other Investing Activities	-	-	-0.03	-	-	-0.59	-0.69	-0.89	-1.15	-2.7	Upgrade
Investing Cash Flow	-0.26	-0.14	73.78	59.36	-0.51	-176.87	-10.71	-73.79	-85.24	-293.83	Upgrade
Share Issuance / Repurchase	0	0	0	0	-0.07	13.45	10.42	75.52	18.1	16.02	Upgrade
Debt Issued / Paid	0	0	-69.66	-1.67	-60.48	-0.66	-2.41	-1.59	0	337.48	Upgrade
Other Financing Activities	-	-	-	-	-	-	53.51	-28	-0.31	-0.19	Upgrade
Financing Cash Flow	0	0	-69.66	-1.67	-60.55	12.8	61.52	45.93	17.79	353.31	Upgrade
Exchange Rate Effect	0.19	0.51	-0.45	1.02	0.06	-0.41	1.23	-2.16	0	0	Upgrade
Net Cash Flow	-14.06	-20.55	-37.67	-2.3	-189.16	-13.69	149.17	-0.36	-28.97	134.13	Upgrade
Free Cash Flow	-14.25	-21.06	-41.51	-65.4	-218.59	117.47	83.45	23.46	32.56	69.57	Upgrade
Free Cash Flow Growth	-	-	-	-	-	40.76%	255.75%	-27.96%	-53.19%	97.39%	Upgrade
Free Cash Flow Margin	-12.11%	-17.76%	-32.16%	-42.75%	-113.61%	24.92%	14.18%	4.51%	6.61%	17.33%	Upgrade
Free Cash Flow Per Share	-11.47	-20.83	-78.17	-161.79	-551.51	299.85	217.69	62.19	92.52	202.86	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).